View in EDS

Improved Speech Intelligibility in Subjects With Stable Sensorineural Hearing Loss Following Intratympanic Dosing of FX-322 in a Phase 1b Study.

Saved in:
Bibliographic Details
Title: Improved Speech Intelligibility in Subjects With Stable Sensorineural Hearing Loss Following Intratympanic Dosing of FX-322 in a Phase 1b Study.
Authors: McLean WJ; Frequency Therapeutics, Woburn, MA & Farmington, CT.; Department of Surgery, University of Connecticut School of Medicine, Farmington, CT., Hinton AS; Frequency Therapeutics, Woburn, MA & Farmington, CT., Herby JTJ; Frequency Therapeutics, Woburn, MA & Farmington, CT., Salt AN; Department of Otolaryngology, Central Institute for the Deaf, Fay and Carl Simons Center for Hearing and Deafness, Washington University School of Medicine, Saint Louis, MO., Hartsock JJ; Department of Otolaryngology, Central Institute for the Deaf, Fay and Carl Simons Center for Hearing and Deafness, Washington University School of Medicine, Saint Louis, MO., Wilson S; Frequency Therapeutics, Woburn, MA & Farmington, CT., Lucchino DL; Frequency Therapeutics, Woburn, MA & Farmington, CT., Lenarz T; Department of Otolaryngology and Cluster of Excellence of the German Research Foundation 'Hearing4all', Hannover Medical School, Hannover, Germany., Warnecke A; Department of Otolaryngology and Cluster of Excellence of the German Research Foundation 'Hearing4all', Hannover Medical School, Hannover, Germany., Prenzler N; Department of Otolaryngology and Cluster of Excellence of the German Research Foundation 'Hearing4all', Hannover Medical School, Hannover, Germany., Schmitt H; Department of Otolaryngology and Cluster of Excellence of the German Research Foundation 'Hearing4all', Hannover Medical School, Hannover, Germany., King S; Ear Medical Group., Jackson LE; Ear Institute of Texas, San Antonio, TX., Rosenbloom J; Alamo ENT Associates, San Antonio, TX., Atiee G; Worldwide Clinical Trials, San Antonio, TX., Bear M; Forsythe and Bear LLC, Woodland Hills, CA., Runge CL; Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, WI., Gifford RH; Department of Hearing and Speech Sciences, Vanderbilt University Medical Center, Nashville, TN., Rauch SD; Department of Otolaryngology, Harvard Medical School and Massachusetts Eye and Ear, Boston., Lee DJ; Department of Otolaryngology, Harvard Medical School and Massachusetts Eye and Ear, Boston., Langer R; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA., Karp JM; Center for Nanomedicine, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School Boston MA.; Harvard-MIT Division of Health Science and Technology.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA., Loose C; Frequency Therapeutics, Woburn, MA & Farmington, CT., LeBel C; Frequency Therapeutics, Woburn, MA & Farmington, CT.
Source: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology [Otol Neurotol] 2021 Aug 01; Vol. 42 (7), pp. e849-e857.
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 100961504 Publication Model: Print Cited Medium: Internet ISSN: 1537-4505 (Electronic) Linking ISSN: 15317129 NLM ISO Abbreviation: Otol Neurotol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33617194
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Improved Speech Intelligibility in Subjects With Stable Sensorineural Hearing Loss Following Intratympanic Dosing of FX-322 in a Phase 1b Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22McLean+WJ%22">McLean WJ</searchLink>; Frequency Therapeutics, Woburn, MA & Farmington, CT.; Department of Surgery, University of Connecticut School of Medicine, Farmington, CT.<br /><searchLink fieldCode="AU" term="%22Hinton+AS%22">Hinton AS</searchLink>; Frequency Therapeutics, Woburn, MA & Farmington, CT.<br /><searchLink fieldCode="AU" term="%22Herby+JTJ%22">Herby JTJ</searchLink>; Frequency Therapeutics, Woburn, MA & Farmington, CT.<br /><searchLink fieldCode="AU" term="%22Salt+AN%22">Salt AN</searchLink>; Department of Otolaryngology, Central Institute for the Deaf, Fay and Carl Simons Center for Hearing and Deafness, Washington University School of Medicine, Saint Louis, MO.<br /><searchLink fieldCode="AU" term="%22Hartsock+JJ%22">Hartsock JJ</searchLink>; Department of Otolaryngology, Central Institute for the Deaf, Fay and Carl Simons Center for Hearing and Deafness, Washington University School of Medicine, Saint Louis, MO.<br /><searchLink fieldCode="AU" term="%22Wilson+S%22">Wilson S</searchLink>; Frequency Therapeutics, Woburn, MA & Farmington, CT.<br /><searchLink fieldCode="AU" term="%22Lucchino+DL%22">Lucchino DL</searchLink>; Frequency Therapeutics, Woburn, MA & Farmington, CT.<br /><searchLink fieldCode="AU" term="%22Lenarz+T%22">Lenarz T</searchLink>; Department of Otolaryngology and Cluster of Excellence of the German Research Foundation 'Hearing4all', Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Warnecke+A%22">Warnecke A</searchLink>; Department of Otolaryngology and Cluster of Excellence of the German Research Foundation 'Hearing4all', Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Prenzler+N%22">Prenzler N</searchLink>; Department of Otolaryngology and Cluster of Excellence of the German Research Foundation 'Hearing4all', Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Schmitt+H%22">Schmitt H</searchLink>; Department of Otolaryngology and Cluster of Excellence of the German Research Foundation 'Hearing4all', Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22King+S%22">King S</searchLink>; Ear Medical Group.<br /><searchLink fieldCode="AU" term="%22Jackson+LE%22">Jackson LE</searchLink>; Ear Institute of Texas, San Antonio, TX.<br /><searchLink fieldCode="AU" term="%22Rosenbloom+J%22">Rosenbloom J</searchLink>; Alamo ENT Associates, San Antonio, TX.<br /><searchLink fieldCode="AU" term="%22Atiee+G%22">Atiee G</searchLink>; Worldwide Clinical Trials, San Antonio, TX.<br /><searchLink fieldCode="AU" term="%22Bear+M%22">Bear M</searchLink>; Forsythe and Bear LLC, Woodland Hills, CA.<br /><searchLink fieldCode="AU" term="%22Runge+CL%22">Runge CL</searchLink>; Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Gifford+RH%22">Gifford RH</searchLink>; Department of Hearing and Speech Sciences, Vanderbilt University Medical Center, Nashville, TN.<br /><searchLink fieldCode="AU" term="%22Rauch+SD%22">Rauch SD</searchLink>; Department of Otolaryngology, Harvard Medical School and Massachusetts Eye and Ear, Boston.<br /><searchLink fieldCode="AU" term="%22Lee+DJ%22">Lee DJ</searchLink>; Department of Otolaryngology, Harvard Medical School and Massachusetts Eye and Ear, Boston.<br /><searchLink fieldCode="AU" term="%22Langer+R%22">Langer R</searchLink>; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Karp+JM%22">Karp JM</searchLink>; Center for Nanomedicine, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School Boston MA.; Harvard-MIT Division of Health Science and Technology.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Loose+C%22">Loose C</searchLink>; Frequency Therapeutics, Woburn, MA & Farmington, CT.<br /><searchLink fieldCode="AU" term="%22LeBel+C%22">LeBel C</searchLink>; Frequency Therapeutics, Woburn, MA & Farmington, CT.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100961504%22">Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology</searchLink> [Otol Neurotol] 2021 Aug 01; Vol. 42 (7), pp. e849-e857.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100961504 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-4505 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215317129%22">15317129 </searchLink><i>NLM ISO Abbreviation: </i>Otol Neurotol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33617194
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1097/MAO.0000000000003120
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e849
    Titles:
      – TitleFull: Improved Speech Intelligibility in Subjects With Stable Sensorineural Hearing Loss Following Intratympanic Dosing of FX-322 in a Phase 1b Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: McLean WJ
      – PersonEntity:
          Name:
            NameFull: Hinton AS
      – PersonEntity:
          Name:
            NameFull: Herby JTJ
      – PersonEntity:
          Name:
            NameFull: Salt AN
      – PersonEntity:
          Name:
            NameFull: Hartsock JJ
      – PersonEntity:
          Name:
            NameFull: Wilson S
      – PersonEntity:
          Name:
            NameFull: Lucchino DL
      – PersonEntity:
          Name:
            NameFull: Lenarz T
      – PersonEntity:
          Name:
            NameFull: Warnecke A
      – PersonEntity:
          Name:
            NameFull: Prenzler N
      – PersonEntity:
          Name:
            NameFull: Schmitt H
      – PersonEntity:
          Name:
            NameFull: King S
      – PersonEntity:
          Name:
            NameFull: Jackson LE
      – PersonEntity:
          Name:
            NameFull: Rosenbloom J
      – PersonEntity:
          Name:
            NameFull: Atiee G
      – PersonEntity:
          Name:
            NameFull: Bear M
      – PersonEntity:
          Name:
            NameFull: Runge CL
      – PersonEntity:
          Name:
            NameFull: Gifford RH
      – PersonEntity:
          Name:
            NameFull: Rauch SD
      – PersonEntity:
          Name:
            NameFull: Lee DJ
      – PersonEntity:
          Name:
            NameFull: Langer R
      – PersonEntity:
          Name:
            NameFull: Karp JM
      – PersonEntity:
          Name:
            NameFull: Loose C
      – PersonEntity:
          Name:
            NameFull: LeBel C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2021 Aug 01
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1537-4505
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
              Type: main
ResultId 1